Abstract
That there has been «littleprogress in the treatment of malignant gliomas» has almost become a cliche in oncology, yet from the past quarter century of effort we have learned a great deal about those empiric covariates that influence survival and have increased the quality and length of survival for some tumors. It has been shown that outcome (survival) for supratentorial gliomas is related to the following covariates: tumor histology and grade, labelling index, age at diagnosis, performance status, post-operative residual tumor volume, and the type and extent of radiation and chemotherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ammirati M et al (1987) Effect of the extend of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurg 21: 201–206
Cairncross JG, MacDonald DR (1988) Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360–364
Deutsch M, Green SB, Strike TA et al (1989) Results of a randomized trial comparing BCNU plus radiotherapy, Streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following Misonidazole plus radiotherapy in the post-operative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 16: 1389–1396
Edwards MS et al (1989) Hyperfractionated radiation therapy for brain-stem glioma: A phase I-II trial. J Neurosurg 70: 691–700
Hoshino T et al (1989) Prognostic implications of the bromodeoxyuridine labelling index of human gliomas. J Neurosurg 71: 335–341
Jeremic B, Jovanovic D, Djuric LJ et al (1992) Advantage of post-radiotherapy chemotherapy with CCNU, Procarbazine, and Vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas. J Chemotherapy 4: 123–126
Levin VA, Sheline GE, Gutin PH (1989) Neoplasms of the central nervous system. In: DeVita VT, Jr, Hellman S, Rosenberg SA (eds) Cancer. Principles and Practice of Oncology. 3rd Edition, JB Lippincott, Philadelphia, pp 1557–1579
Levin VA et al (1980) Prognostic significance of the pretreatment CT scan on time to progression for patients with malignant gliomas. J Neurosurg 52: 642–647
Levin VA, Silver P, Hannigan J et al (1990) Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, Procarbazine, and Vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321–324
Levin VA, Prados MD, Yung WA et al (1992) Treatment of recurrent gliomas with Eflornithine, J Natl Cancer Inst 84: 1432–1437
Levin VA, Prados MD (1993) Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J Clin Oncol 10: 766–771
Shapiro WR, Green SB, Burger PC et al (1989) Randomized trial for three chemotherapy regimens and two radiotherapy regimens in post-operative treatment of malignant glioma. Brain Tumor Coop Group Trail 8001. J Neurosurg 71: 1–9
Walker MD, Green SN, Byar DP et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for malignant glioma after surgery. N Engl J Med 303: 1323–1329
Wood JR, Green SB, Shapiro WR (1988) The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Coop Group. J Clin Oncol 6: 338–343
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag France
About this paper
Cite this paper
Levin, V. (1994). Present and future prospects for the chemotherapy of gliomas. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_13
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0765-2_13
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0767-6
Online ISBN: 978-2-8178-0765-2
eBook Packages: Springer Book Archive